Ascendis Pharma A/S (ASND) Q4 2021 Earnings Call

Investor webinar replay

Meeting Overview The Q4 2021 Ascended Pharma Earnings Conference Call focused on the company's financial results for the year and provided updates on their product pipeline and strategic goals. Key highlights included the regulatory approvals of their products and plans for future growth and commercialization. Key Discussion Points - Overview of the financial results for the full year 2021. - Regulatory approvals of Transcon HGH in the U.S. and Europe. - Progress on pipeline candidates and their potential market impact. - Strategic goals under the "vision 3x3" framework. - Updates on clinical development in oncology and endocrinology. - Plans for the commercial launch of SkyTropha in the U.S. and Europe. Decisions Made - No explicit decisions recorded. Action Items & Next Steps - [Unassigned] : Share data and regulatory milestones across the five independent clinical programs throughout 2022. - [Unassigned] : Provide updates related to the commercial launch of SkyTropha in the U.S. ...

Watch the replay

Replay transcript excerpt

[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good day and thank you for standing by. Welcome to the Q4 [00:04] Speaker 1: 2021 Ascended Pharma Earnings Conference Call. [00:08] Speaker 1: At this time, all participants are in a listen-only mode. [00:11] Speaker 1: After the speaker's presentation, there will be a question and answer session. [00:15] Speaker 1: To ask a question during that session, you will need to press star 1 on your telephone. [00:20] Speaker 1: Please be advised that today's conference is being recorded. [00:24] Speaker 1: And if you require any assistance during the call, please press star 1. [00:29] Speaker 1: I would now like to hand the conference over to your speaker today, Mr. Tim Lee, Senior Director of Investor Relations. [00:35] Speaker 1: Tim Lee, the floor is yours. [00:39] Speaker 2: Thank you, Operator. [00:40] Speaker 2: Thank you everyone for joining our full year 2021 Financial Results Conference call today. I'm Tim Lee, Senior Director, Investor Relations of Ascendus Pharma. [00:51] Speaker 2: Joining me on today's call is Yen Mickelson, President and Chief Executive Officer. [00:57] Speaker 2: Scott Smith, Senior Vice President and Chief Financial Officer. [01:01] Speaker 2: Jesper Heulen, [01:03] Speaker 2: Global Chief Commercial Officer. [01:06] Speaker 2: Dr. Dana Pizzuti, head of development operations and chief medical officer, [01:12] Speaker 2: Dr. Yuhab Poonanen, head of oncology, [01:15] Speaker 2: and Dr. Steena Singhal, [01:17] Speaker 2: head of clinical development oncology. [01:20] Speaker 2: Before we begin, I would like to remind you that this conference call will contain forward-looking statements that are intended to be covered under the [01:28] Speaker 2: safe harbor prov...